Results for the 2010 RCVS Council elections have been released today and, following a slight increase in turnout for the second year running, four existing Council Members and one former Member have been returned for another four years. However, new to Council this year and securing the most votes was Preston-based veterinary practitioner David Catlow.

4,232 veterinary surgeons out of a possible 22,541 cast their votes this year, an increase of 0.6% from 18.2% in 2009. The results of the voting are as follows:

CATLOW, David Frederick. 2,383. Elected.
TAPSFIELD-WRIGHT. Clare Joan. 2,352. Elected.
SHIELD, Christine Fiona. 2,133. Elected.
MOLYNEUX, Jacqueline Rosina. 2,111. Elected.
SMITH, Neil Christopher. 2,089. Elected.
PARTRIDGE, Robert Duncan. 1,971. Elected.
NELL, Adi. 1,781.            
ANDERSON, Roy Paxton. 1,455.           
GODDARD, Philip Campbell. 1,385.            
LONSDALE, Thomas, 380. 

Terms of office for the six successful candidates will (re)commence at RCVS Day on 2 July 2010.

Following a successful partnership last year, the RCVS again teamed up with this website to allow voters more opportunity to quiz the candidates directly and find out more about their views.

Once again, this seemed to prove popular with the electorate although it presented candidates with a large increase in their workload during the voting period. Page views in the election section rose 23% to 28,347 this year; 48 discussion threads were started (slightly down from 53) and total responses rose dramatically by 47% to 988.

A new incentive for members to vote this year was a pledge to donate 20p per voter to the DEC Haiti Earthquake Appeal. A donation of just over £845 will therefore be made shortly.

RCVS Registrar Jane Hern said: "An increase in turnout, if only a small one, is to be welcomed and I hope we can continue to increase members' interest in the composition and activities of RCVS Council. I'd like to thank all ten candidates who stood for election this year; my congratulations to those elected and my commiserations to those who weren't successful this time."

Note: there was no VN Council election this year as only two nominations were received for the two available places. These will be filled by Suzanne May RVN and Hilary Orpet RVN.

Willows, the Solihull-based multidisciplinary referral centre, has announced that it has acquired The Veterinary Cardiorespiratory Centre, the renowned referral service run by Mike Martin MRCVS, RCVS Specialist in Veterinary Cardiology (pictured right).

Mike, together with Chris Linney and their team will shortly be moving half-an-hour up the road to join the team at Willows. 

The company says that the move will offer a number of benefits to referring practitioners. Chief amongst these is the speed with which an accurate diagnosis can be made and treatment given, both as a result of having RCVS Specialists in neurology, imaging, medicine, soft tissue surgery (and now cardiology) under one roof and because of the state-of-the-art equipment at their disposal, including CT, MRI and digital fluoroscopy.

Lynne Hill, CEO, Willows Group said: ”I’m thrilled that Mike, Chris and their team are joining us at Willows. I have always held Mike in the highest regard and this is a tremendous opportunity for the practice to provide a truly collaborative ‘one-stop-shop’ for both clients and referring veterinary practices”.

Mike said: “I’m really looking forward to working at Willows Referral Service and being part of a multidisciplinary team. It's a logical move to provide Willows with the missing discipline of cardiology and I'm delighted Lynne Hill has allowed us to fulfil that role. There has been an increasing number of referrals between the two centres due to the complexity of cases - now that will be all under one roof and we can manage these much more effectively and offer the best service to our clients and their patients.” 

For more information, visit www.willows.uk.net 

Boehringer Ingelheim has launched Aservo EquiHaler (ciclesonide inhalation solution), the first inhaled treatment for equine asthma.

The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally for human use by its pharma business - to deliver medication deep into the horse's lungs.

The active ingredient in the Aservo EquiHaler is ciclesonide, a corticosteroid that is activated directly in the lung, reducing the lower airway inflammation associated with severe equine asthma and reducing the risks commonly associated with systemic corticosteroids.

The Aservo EquiHaler does not use a propellant, so it does not contribute to greenhouse gas emissions. Boehringer also highlights that it is made from up to 50% recycled materials. In April, the product was awarded a Red Dot Design Award.

Dr Marc Laemmer, Head of Equine in UK & Ireland said: "It's another industry first and is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.

"We understand that a product launch in this challenging time for the veterinary profession may seem surprising, but we have had such strong demand from equine vets for the product that we have committed to making Aservo EquiHaler available. Out team of territory managers and vet advisers will conduct remote meetings with customers to make sure that they have the information and support they require."

Portsmouth-based Simon Wood has been struck off by the RCVS Disciplinary Committee after being convicted of possessing indecent images of children.

Mr Wood was convicted of three offences which involved the download of 38 videos and 13 indecent images of children, at Portsmouth Magistrates’ Court in December 2017.

In January 2018, he was sentenced to a three-year Community Sentence for each offence, to run concurrently, and was made subject to a five-year Sexual Harm Prevention Order.

He was also fined £1,000 and ordered to pay costs of £340 and a victim surcharge of £85.

Mr Wood was also placed on the barring list by the Disclosure and Barring Service and required to register with the police pursuant to the Sexual Offences Act 2003 for a period of five years.

Mr Wood appeared before the Disciplinary Committee, admitted his conviction and accepted that it rendered him unfit to practise veterinary surgery.

In determining the sanction, the Committee says it took into account a number of mitigating factors: his conviction involved no actual harm or risk of harm to an animal; there was no financial gain; he had engaged in open and frank admissions at an early stage; he was experiencing mental ill-health at the time of the offence; he had taken subsequent steps to avoid a repetition of such behaviour; there had been a significant lapse of time since the incident; and he showed insight into the harm caused by his offence. 

The Committee also considered that the purpose of a sanction is not to punish, but to protect the welfare of animals, as well as maintain public confidence in the profession and declare and uphold proper standards of conduct. On consideration of the appropriate sanction, the Committee decided that postponement of judgement was not appropriate, and that taking no action was not an option. 

The Committee then considered whether a reprimand or warning was appropriate, but they considered that would not match the gravity of the offence – a period of suspension would also mean Mr Wood would automatically return to the Register after the period of time without the College being able to review his fitness to practise, rendering it an inappropriate sanction. The Committee therefore determined that the removal of Mr Wood from the RCVS Register was the only way to protect the wider public interest and maintain confidence in the profession.

Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has not taken this decision lightly, and, lest it be misinterpreted, it has not taken it in order to satisfy any notional public demand for blame and punishment.

"It has taken the decision because in its perception, the reputation of the profession had to be at the forefront of its thinking and ultimately it was more important than the interests of the Respondent.

"The decision is not simply based on the fact that these offences were of a sexual nature but because they were repeated frequently over a significant period of time, and at the time, the Respondent knew on his own admission that what he was doing was wrong.

"Accordingly, the Committee had decided that removal from the Register is appropriate and proportionate in this case. The Committee will direct the Registrar to remove the Respondent’s name from the Register forthwith."

Mr Wood has 28 days to appeal the Committee’s decision after which, if no appeal is received, the Committee’s judgment takes effect.

The RCVS Disciplinary Committee has ended an enquiry against a Cambridgeshire-based veterinary surgeon who had repeatedly breached court orders relating to the control of dogs, after finding that it did not render him unfit to practise.

Amir Kashiv faced a charge of being unfit to practise veterinary surgery after twice being found guilty of letting dogs roam freely on public highways or land not owned or controlled by him in Peterborough Magistrates’ Court, once on 20 April 2016 and once on 16 November 2016, and by having repeatedly breached court orders in relation to the same.

Dr Kashiv admitted the convictions, but denied that individually or in any combination they rendered him unit to practise veterinary surgery. This was therefore left to the judgement of the Committee.

In considering whether the convictions rendered Dr Kashiv unfit for practice, the Committee first considered the facts of the convictions.

Dr Kashiv had long taken in house dogs with physical and behavioural problems, at some stages having as many as 30 on his property. In 2014 neighbours became concerned by dogs escaping and noise nuisances, and on 14 November 2014 Dr Kashiv was served by the Police with a Warning Notice, requiring him to install adequate fencing within 28 days.

Four days later he was then served with an Abatement Notice for a Noise Nuisance about the dogs, and on 10 January 2015 he was then served with a Community Protection Notice requiring him to stop his dogs roaming and ensure adequate fencing.

After multiple subsequent escapes Dr Kashiv pleaded guilty of being in breach of the Community Protection Order at the Magistrates’ Court on 20 April 2016, receiving penalties amounting to £5,000 and costs of £6,000, as well as a two year Criminal Behaviour Order requiring him to reduce the number of dogs to no more than five with 28 days, and requiring his dogs to be supervised at all times while they were outside the house. 

Two months later one of the dogs was seen outside the property, resulting in another conviction for breach of the Criminal Behaviour Order on 16 November 2016, and Dr Kashiv was fined £250 as well as £250 in costs.

The Committee then considered whether this resulted in Dr Kashiv being unfit to practise veterinary surgery. It considered it a serious matter that a veterinary surgeon should allow himself to be made subject to a Warning Notice, and that, being subject to such a Notice, he should then be found in repeated breach of the Notice and invite prosecution. While the Committee accepts that it is difficult to fence his entire grounds, ten acres in total, the Committee took it as a mark against Dr Kashiv that he failed to address the concerns of the authorities by reducing the number of dogs he housed until he was compelled to do so.

Jane Downes, who was chairing the Committee and speaking on its behalf, said: "The Committee regards this as a case close to borderline. These offences, involving the mismanagement by a veterinary surgeon of his animals and repeated offences demonstrate that Dr Kashiv had a less than adequate insight in 2014 and 2015 into the seriousness of the situation or into the understandable concerns of his neighbours and of the authorities. They are capable of bringing the profession into disrepute so as to undermine public confidence in it.

"But, in the end, The Committee has concluded that Dr Kashiv is not unfit by reason of these convictions to practise as a veterinary surgeon. 

"It is apparent from the material before the Committee that Dr Kashiv is a dedicated veterinary surgeon whose life’s work has been devoted to the welfare of small animals and who has gone to extraordinary lengths, at his own expense, to do all that he possibly could to alleviate the suffering of, and rehabilitate, unloved and abandoned and unwell dogs.

"In all the circumstances and in the light of all the evidence the Committee finds that the convictions, whether taken individually or in any combination, do not render Dr Kashiv unfit to practice veterinary surgery."

Virbac is hosting a free CPD webinar on the role of trace minerals in cattle health and performance.

The webinar, which will be streamed live at 8pm on Wednesday 20^th November and will be available to watch for six months thereafter, is being presented by James Husband, an RCVS Specialist in cattle health & production.

Topics will include oxidative stress, its impact on cattle performance and the role of trace minerals in immunity and cattle health. The webinar will also cover the current complexities of oral supplementation including absorption and mineral antagonism, along with offering information about the latest innovation to boost trace mineral availability during high demand periods in the production and breeding life cycle.

To register for the webinar, visit: https://www.thewebinarvet.com/pages/register-free-role-trace-minerals-cattle-health-performance-new-veterinary-approach-boost-trace-mineral-availability/

All vets who view the webinar, either live or as a recording on the website, will be able to download a CPD certificate.

Virbac has announced the launch of Zenifel, a feline facial pheromone plug-in diffuser billed as the first and only alternative to the current market leader.

Zenifel contains synthetic feline facial pheromones which imitate the facial F3 pheromone which has been found to be significantly important when it comes to cats creating areas they feel safe and relaxed in¹.

According to the company, Zenifel contains a 48ml vial of the same synthetic F3 feline facial pheromone as the market leader, but, thanks to its own diffusion system and a higher concentration of F3, lasts up to 6 weeks; i.e. 50% longer. This, says Virbac, means that Zenifel is both more economical and more environmentally friendly.

Alongside the launch of the new product, Virbac is offering a practice support pack which includes things you need to create a calm area for feline visitors and promote the benefits of pheromones to pet owners. The company is also running a promotion in which practices could be eligible for a year’s free supply of Zenifel.

For more information, contact your local Virbac Territory Manager.

Reference

1. Amat M., Camps T., Manteca X. (2016) Stress in owned cats: behavioural changes and welfare implications. J Feline Med Surg. 18(8):577-586.10.1177/1098612X15590867

The BSAVA has produced a triage tool designed to help staff in small animal practice identify and process emergency canine and feline cases during the coronavirus pandemic.

The tool is available to all practices, free of charge. 

The downloadable and printable guide chart, which has been created by a number of specialists, will help veterinary surgeons, nurses and receptionists to identify urgent, potentially urgent, non-urgent and delayable cases to help limited veterinary resources be used to best efficiency without compromise to animal health or welfare.

The chart, which can be printed and put on a practice wall or referred to as a webpage via a mobile phone or tablet, has a number of supporting resources produced by the same specialists.

Sue Paterson, BSAVA President, said: “During these exceptional and worrying times veterinary surgeons need as much practical help and support as possible.

"We are hugely grateful for the indefatigable support of an enthusiastic group of volunteers who have rapidly produced this triage tool, which we are now able to share. It should enable patient queries to be processed, reliably and efficiently, allowing for emergency patients to be seen as a matter of urgency, within the current government and RCVS guidelines."

The triage tool is free to download and share: https://www.bsava.com/TriageTool

BSAVA is working on a number of other initiatives to support veterinary professionals during the current crisis, including new guidance on obtaining consent remotely for veterinary treatment. for more information, visit: https://www.bsava.com/adviceforCOVID19 

Davies Veterinary Specialists reports that it has performed its first corneal xenograft on a Chihuahua with a melting corneal ulcer. 

The dog, called Pepe, needed urgent treatment to repair the cornea before it ruptured, so the team at Davies decided to use a new xenograft derived from a pig cornea, rather than waiting to see if an allograft became available.

The xenograft, which was developed in China, is aseptically prepared, sterilised and freeze-dried so it can be stored for months or years if necessary before use.

According to Davies, the graft had been used in China and the USA, where the early results had been promising. Now, following Pepe's successful treatment, Davies is now using the procedure in more cases over here in the UK. 

The full case study, with photos, is here: https://www.vetsurgeon.org/veterinary-clinical/small-animal/sa-ophthalmology/m/photo-video-media/138076.aspx

For more information, visit: https://vetspecialists.co.uk/services/ophthalmology/ 

Boehringer Ingelheim has launched Vetmedin (pimobendan) 1.5 mg/ml oral solution for dogs in Great Britain, offering a new treatment option for smaller cardiac patients and ones that don't take tablets easily.

The company says the two main benefits of the liquid formulation are precise dosing and ease of administration. 

Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.

The maximum syringe volume is for a 12 kg dog.

The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.

These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.

The company highlights the EPIC¹ and PROTECT² studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.

Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.

VetMedin oral solution is now available to order from wholesalers.

References

1. Boswood A, Häggström J, Gordon SG, et al. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial. J Vet Intern Med. 2016 Nov;30(6):1765-1779. doi: 10.1111/jvim.14586. Epub 2016 Sep 28. 
2. Summerfield et al. Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study). J Vet Intern Med 2012;26:1337-1349.

Paragon Veterinary Referrals in Wakefield has been joined by Dr Rodney Ayl, a double-board certified specialist in medical and radiation oncology.

Rodney (pictured right) has spent the last 26 years practising in the USA, latterly at the California-based Advanced Veterinary Specialists & Animal Specialty Group.

After growing up in Zimbabwe and graduating from the University of Pretoria in South Africa in 1985, he moved to London, where he became an MRCVS, and thence to the USA.

He undertook a small animal internship at the Animal Medical Centre in Manhattan, before moving to the Ohio State University for his residency in medical oncology in 1989. He achieved Board Certification in medical oncology in 1994 and in radiation oncology in 2000.

Rodney specialises in the application of multi-modality therapy protocols for the treatment of cancer in animals, and has conducted research on the phenomenon of multi-drug resistance, mast cell tumour and oral melanoma.

He said: "Thirty-something years on, I have come back to the UK as a specialist, where I started as a GP. Living in the UK also brings me much closer to my family, which is very important to me.

"Over the years, veterinary practice in the USA has changed significantly, where it has become more corporate and less personal. I enjoy being part of a new group where typically it is much closer, friendlier and more like a family."

Rodney now plans to oversee the development of a comprehensive oncology department to include chemotherapy, surgery, radiation therapy, immune-therapy and molecular targeted therapy.

He said his work at Paragon will focus on educating referring vets and clients about what is possible in the oncology field.

He said: "My job will be about increasing the level of knowledge, both of owners and general practitioners, of how we treat cancer in animals.

"It can be a scary disease and the first door an owner needs to step through, is understanding that treating a pet is very different to treating a human.

"The intention in humans is usually to cure but with pets, it is more about providing a good quality of life for as long as possible.

"There can be a fear of cancer therapy but if you stick to the protocols, it is no different to treating any other chronic incurable diseases. We use the safest methods with an abundance of caution and try to make sure that the treatment is not worse than the disease.

"It’s about internal training too, from reception right up to nurses and interns, looking at what we do and how we do it, to optimize the quality of life of the pet and their owners.

"I would like to see an oncology department that considers the emotional, financial, time and patient concerns of the owners, so they feel their commitment to cancer treatment for their pet is not a commitment to putting their pet or themselves through a difficult time."

Boehringer Ingelheim, manufacturer of Prascend, has launched www.careaboutcushings.co.uk, an information resource for horse owners.

The Care About Cushing’s website is designed to give horse owners the information they need to spot the signs of Cushing's, thereby prompting diagnosis by their veterinary surgeon.

The online resource includes monitoring tools, personalised alerts, owner guides and webinars. It also offers downloadable self-assessment checklists on Cushing’s disease and laminitis to take owners through the signs to look out for.

Owners whose horses have been diagnosed with Cushing’s are encouraged to sign up as a Care About Cushing’s member to keep up-to-date with the latest information about the disease and create a personal profile for their horse in order to monitor progress. One of the membership benefits is an 'ask the expert' section where members can ask questions about Cushing’s disease and laminitis.

The Care About Cushing’s resource supports Boehringer’s ‘Talk About Laminitis’ initiative to raise awareness of the signs of laminitis and its link with Cushing’s disease.

Talk About Laminitis now runs throughout the year and as part of the campaign the laboratory fees for the blood test which detects Cushing’s (the basal ACTH test) are free. 

Liz Barrett, equine business head at Boehringer, said: "Our Talk About Laminitis disease awareness initiative has been hugely successful in highlighting the link between laminitis and Cushing’s disease and helping to diagnose Cushing’s. So much so that Cushing’s is now in the top five equine diseases recorded in the UK¹."

For further information on Talk About Laminitis or Care About Cushing’s, visit www.talkaboutlaminitis.co.uk, www.careaboutcushings.co.uk or contact your local Boehringer territory manager.

Reference

1. National Equine Health Survey (NEHS) 2017